Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Weiye Li MD, PhD
Weiye Li MD, PhD Advisory Board
Aparna Ramasubramanian MD
Aparna Ramasubramanian MD Advisory Board
Joseph Sassani MD
Joseph W. Sassani MD Associate Editor
See All Experts
Published in Eye Care

Journal Scan / Research · July 02, 2023

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Patients With Neovascular AMD

JAMA Ophthalmology

 

 Save  Recommend
 Share

Additional Info

JAMA Ophthalmology
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial
JAMA Ophthalmol 2023 Jun 08;[EPub Ahead of Print], SJ Woo, M Bradvica, A Vajas, M Sagong, J Ernest, J Studnicka, M Veith, E Wylegala, S Patel, C Yun, M Orski, S Astakhov, E Tóth-Molnár, A Csutak, L Enyedi, T Kim, I Oh, H Jang, SR Sadda

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated